p.80 抽出テキスト

CLINICAL STATEMENTS AND GUIDELINES

August 29, 2023 Circulation. 2023;148:e9–e119. DOI: 10.1161/CIR.0000000000001168

Virani et al 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Chronic Coronary Disease Guideline

27.	 Scirica BM, Cannon CP, Fisher NDL, et al. Digital care transformation: interim report from the first 5000 patients enrolled in a remote algorithm-based cardiovascular risk management program to improve lipid and hypertension control. Circulation. 2021;143:507–509. 28.	 Peric VM, Borzanovic MD, Stolic RV, et al. Severity of angina as a predictor of quality of life changes six months after coronary artery bypass surgery. Ann Thorac Surg. 2006;81:2115–2120. 29.	 Rumsfeld JS, Magid DJ, O'Brien M, et al. Changes in health-related quality of life following coronary artery bypass graft surgery. Ann Thorac Surg. 2001;72:2026–2032. 30.	 Rumsfeld JS, Magid DJ, Plomondon ME, et al. Predictors of quality of life following acute coronary syndromes. Am J Cardiol. 2001;88:781–784. 31.	 Chan PS, Jones PG, Arnold SA, et al. Development and validation of a short

version of the Seattle angina questionnaire. Circ Cardiovasc Qual Outcomes. 2014;7:640–647. 4.1.1. Team-Based Approach 1.	 Chisholm-Burns MA, Kim Lee J, Spivey CA, et al. US pharmacists' effect as team members on patient care: systematic review and meta-analyses. Med Care. 2010;48:923–933. 2.	 Fazel MT, Bagalagel A, Lee JK, et al. Impact of diabetes care by pharmacists as part of health care team in ambulatory settings: a systematic review and meta-analysis. Ann Pharmacother. 2017;51:890–907. 3.	 Mills KT, Obst KM, Shen W, et al. Comparative effectiveness of implementation strategies for blood pressure control in hypertensive patients: a systematic review and meta-analysis. Ann Intern Med. 2018;168:110–120. 4.	 Proia KK, Thota AB, Njie GJ, et al. Team-based care and improved blood pressure control: a community guide systematic review. Am J Prev Med. 2014;47:86–99. 5.	 Wan EYF, Fung CSC, Jiao FF, et al. Five-year effectiveness of the multidisciplinary risk assessment and management programme-diabetes mellitus (RAMP-DM) on diabetes-related complications and health service uses: a population-based and propensity-matched cohort study. Diabetes Care. 2018;41:49–59. 6.	 Chen S-M, Fang Y-N, Wang L-Y, et al. Impact of multi-disciplinary treatment strategy on systolic heart failure outcome. BMC Cardiovasc Disord. 2019;19:1–7. 7.	 Jiao F, Fung CS, Wan YF, et al. Long-term effects of the multidisciplinary risk assessment and management program for patients with diabetes mellitus (RAMP-DM): a population-based cohort study. Cardiovasc Diabetol. 2015;14:105. 8.	 Snaterse M, Dobber J, Jepma P, et al. Effective components of nurse-coordinated care to prevent recurrent coronary events: a systematic review and meta-analysis. Heart. 2016;102:50–56. 9.	 Virani SS, Akeroyd JM, Ramsey DJ, et al. Health care resource utilization for outpatient cardiovascular disease and diabetes care delivery among advanced practice providers and physician providers in primary care. Popul Health Manag. 2018;21:209–216. 10.	 Rajan SS, Akeroyd JM, Ahmed ST, et al. Health care costs associated with primary care physicians versus nurse practitioners and physician assistants. J Am Assoc Nurse Pract. 2021;33:967–974. 11.	 Carter BL, Levy B, Gryzlak B, et al. Cluster-randomized trial to evaluate a centralized clinical pharmacy service in private family medicine offices. Circ Cardiovasc Qual Outcomes. 2018;11:e004188. 12.	 Tapsell LC, Neale EP. The effect of interdisciplinary interventions on risk factors for lifestyle disease. Health Educ Behav. 2016;43:271–285. 13.	 Carter BL, Rogers M, Daly J, et al. The potency of team-based care interventions for hypertension: a meta-analysis. Arch Intern Med. 2009;169:1748– 1755. 14.	 Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140:e596–e646. 15.	 Buhse S, Muhlhauser I, Heller T, et al. Informed shared decision-making programme on the prevention of myocardial infarction in type 2 diabetes: a randomised controlled trial. BMJ Open. 2015;5:e009116. 16.	 Chen EH, Thom DH, Hessler DM, et al. Using the Teamlet Model to improve chronic care in an academic primary care practice. J Gen Intern Med. 2010;25(suppl 4):S610–S614. 17.	 Chen Z, Ernst ME, Ardery G, et al. Physician-pharmacist co-management and 24-hour blood pressure control. J Clin Hypertens (Greenwich). 2013;15:337–343. 18.	 Cooper LA, Roter DL, Carson KA, et al. A randomized trial to improve pa-

tient-centered care and hypertension control in underserved primary care patients. J Gen Intern Med. 2011;26:1297–1304. 19.	 Fentanes E, Vande Hei AG, Holuby RS, et al. Treatment in a preventive cardiology

clinic utilizing advanced practice providers effectively closes atherosclerotic cardiovascular disease risk-management gaps among a primary-prevention population compared with a propensity-matched primary-care cohort: a teambased care model and its impact on lipid and blood pressure management. Clin Cardiol. 2018;41:817–824. 20.	 Hirsch JD, Steers N, Adler DS, et al. Primary care-based, pharmacist-physician collaborative medication-therapy management of hypertension: a randomized, pragmatic trial. Clin Ther. 2014;36:1244–1254. 21.	 Hunt JS, Siemienczuk J, Pape G, et al. A randomized controlled trial of teambased care: impact of physician-pharmacist collaboration on uncontrolled hypertension. J Gen Intern Med. 2008;23:1966–1972. 22.	 Isetts BJ, Buffington DE, Carter BL, et al. Evaluation of pharmacists' work in a physician-pharmacist collaborative model for the management of hypertension. Pharmacotherapy. 2016;36:374–384. 23.	 Kravetz JD, Walsh RF. Team-based hypertension management to improve blood pressure control. J Prim Care Community Health. 2016;7:272–275. 24.	 McLean DL, McAlister FA, Johnson JA, et al. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN). Arch Intern Med. 2008;168:2355–2361. 25.	 Olomu A, Hart-Davidson W, Luo Z, et al. Implementing shared decision making in federally qualified health centers, a quasi-experimental design study: the Office-Guidelines Applied to Practice (Office-GAP) program. BMC Health Serv Res. 2016;16:334. 26.	 Parchman ML, Zeber JE, Palmer RF. Participatory decision making, patient activation, medication adherence, and intermediate clinical outcomes in type 2 diabetes: a STARNet study. Ann Fam Med. 2010;8:410–417. 27.	 Polgreen LA, Han J, Carter BL, et al. Cost-effectiveness of a physicianpharmacist collaboration intervention to improve blood pressure control. Hypertension. 2015;66:1145–1151. 28.	 Fors A, Ekman I, Taft C, et al. Person-centred care after acute coronary syndrome, from hospital to primary care-a randomised controlled trial. Int J Cardiol. 2015;187:693–699. 29.	 Jiao FF, Fung CS, Wong CK, et al. Effects of the Multidisciplinary Risk Assessment and Management Program for Patients with Diabetes Mellitus (RAMP-DM) on biomedical outcomes, observed cardiovascular events and cardiovascular risks in primary care: a longitudinal comparative study. Cardiovasc Diabetol. 2014;13:127. 30.	 Smith SM, Carris NW, Dietrich E, et al. Physician-pharmacist collaboration versus usual care for treatment-resistant hypertension. J Am Soc Hypertens. 2016;10:307–317. 31.	 Camacho EM, Davies LM, Hann M, et al. Long-term clinical and costeffectiveness of collaborative care (versus usual care) for people with mental-physical multimorbidity: cluster-randomised trial. Br J Psychiatry. 2018;213:456–463. 32.	 Jiang W, Zhang Y, Yan F, et al. Effectiveness of a nurse-led multidisciplinary self-management program for patients with coronary heart disease in communities: a randomized controlled trial. Patient Educ Couns. 2020;103:854– 863. 33.	 Lin EH, Von Korff M, Ciechanowski P, et al. Treatment adjustment and medication adherence for complex patients with diabetes, heart disease, and depression: a randomized controlled trial. Ann Fam Med. 2012;10:6–14. 34.	 Maru S, Byrnes J, Carrington MJ, et al. Economic evaluation of a nurse-led home and clinic-based secondary prevention programme to prevent progressive cardiac dysfunction in high-risk individuals: The Nurse-led Intervention for Less Chronic Heart Failure (NIL-CHF) randomized controlled study. Eur J Cardiovasc Nurs. 2018;17:439–445. 35.	 Virani SS, Maddox TM, Chan PS, et al. Provider Type and Quality of Outpatient Cardiovascular Disease Care: Insights From the NCDR PINNACLE Registry. J Am Coll Cardiol. 2015;66:1803–1812. 36.	 Brush JE Jr, Handberg EM, Biga C, et al. 2015 ACC health policy state-

ment on cardiovascular team-based care and the role of advanced practice providers. J Am Coll Cardiol. 2015;65:2118–2136. 4.1.2. Patient Education 1.	 Ghisi GL, Abdallah F, Grace SL, et al. A systematic review of patient education in cardiac patients: do they increase knowledge and promote health behavior change?. Patient Educ Couns. 2014;95:160–174. 2.	 Elnaem MH, Rosley NFF, Alhifany AA, et al. Impact of pharmacist-led inter-

ventions on medication adherence and clinical outcomes in patients with hypertension and hyperlipidemia: a scoping review of published literature. J Multidiscip Healthc. 2020;13:635–645.

Downloaded from http://ahajournals.org by on October 7, 2026